Quick answer: latest quarter results, by ticker or company name

FONAR Corporation (FONR)

Healthcare | Medical Devices

Swipe horizontally to view all columns.

Income Statement (Quarterly)	2025-09-30	2025-03-31	2024-12-31	2024-09-30
Revenue	26,043,000	2,025,000	24,950,000	24,960,000
Cost of Revenue	15,596,000	4,901,000	15,212,000	14,917,000
Gross Profit	10,447,000	-2,876,000	9,738,000	10,043,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	0	7,991,000	6,927,000	5,130,000
Operating Expenses	7,253,000	18,602,000	7,303,000	5,437,000
Operating Income	3,194,000	3,662,000	2,435,000	4,606,000
Interest Expense	1,000	-7,000	6,000	8,000
Income Before Tax	3,682,000	4,130,000	2,967,000	5,249,000
Income Tax Expense	1,012,000	-1,006,000	762,000	1,249,000
Net Income	2,264,000	5,136,000	1,964,000	3,135,000
Per Share
EPS	0.10	0.11	0.29	0.47
EPS Diluted	0.00	0.00	0.00	0.00

Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Revenue	104,351,318	102,884,089	98,645,101	97,592,145	89,929,765
Cost of Revenue	19,130,935	57,744,044	52,897,158	50,578,201	46,456,127
Gross Profit	85,220,383	45,140,045	45,747,943	47,013,944	43,473,638
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	29,734,163	26,868,732	29,390,932	23,512,581	24,740,044
Operating Expenses	73,621,626	28,604,681	30,958,681	25,006,762	26,376,023
Operating Income	11,598,757	16,535,364	14,789,262	22,007,182	17,097,615
Interest Expense	25,611	76,997	50,131	346,552	248,665
Income Before Tax	13,780,238	19,266,385	15,758,587	22,768,875	17,665,331
Income Tax Expense	3,106,805	5,168,968	3,632,071	5,534,487	3,991,520
Net Income	8,334,261	10,567,396	9,375,776	17,234,388	10,207,588
Per Share
EPS	1.26	1.49	1.35	2.59	1.47
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-12-31
Assets
Cash and Cash Equivalents	56,333,636	56,341,193	51,279,707	49,505,000
Short Term Investments	120,494	136,102	32,799	32,000
Net Receivables	82,944,279	79,845,587	70,170,897	3,949,000
Inventory	2,812,682	2,715,441	2,569,666	2,634,000
Total Current Assets	144,671,810	140,324,285	125,660,837	120,749,000
Property Plant Equipment	54,044,900	57,667,025	55,944,357	56,563,000
Goodwill and Intangibles	7,261,480	7,139,601	7,701,142	7,846,000
Total Assets	216,907,877	214,245,969	200,581,887	197,498,000
Liabilities
Account Payables	1,302,317	1,855,879	1,579,240	866,000
Short Term Debt	3,626,912	3,746,460	4,166,848	4,208,000
Total Current Liabilities	17,124,406	17,857,080	15,624,373	13,745,000
Long Term Debt	35,291,430	37,929,407	32,840,961	34,004,000
Total Liabilities	56,803,257	57,457,580	49,754,747	49,428,000
Shareholders Equity
Retained Earnings	-5,289,324	-13,623,585	-24,190,981	0
Total Shareholders Equity	172,608,186	165,967,997	157,906,433	148,070,000

Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-12-31	2022-09-30
Assets
Cash and Cash Equivalents	56,333,636	56,341,193	51,279,707	49,505,000	48,696,000
Short Term Investments	120,494	136,102	32,799	32,000	32,000
Net Receivables	82,944,279	79,845,587	70,170,897	3,949,000	4,161,000
Inventory	2,812,682	2,715,441	2,569,666	2,634,000	2,458,000
Total Current Assets	144,671,810	140,324,285	125,660,837	120,749,000	119,066,000
Property Plant Equipment	54,044,900	57,667,025	55,944,357	56,563,000	57,265,000
Goodwill and Intangibles	7,261,480	7,139,601	7,701,142	7,846,000	7,893,000
Total Assets	216,907,877	214,245,969	200,581,887	197,498,000	198,022,000
Liabilities
Account Payables	1,302,317	1,855,879	1,579,240	866,000	773,000
Short Term Debt	3,626,912	3,746,460	4,166,848	4,208,000	4,162,000
Total Current Liabilities	17,124,406	17,857,080	15,624,373	13,745,000	14,873,000
Long Term Debt	35,291,430	37,929,407	32,840,961	34,004,000	34,044,000
Total Liabilities	56,803,257	57,457,580	49,754,747	49,428,000	50,892,000
Shareholders Equity
Retained Earnings	-5,289,324	-13,623,585	-24,190,981	0	0
Total Shareholders Equity	172,608,186	165,967,997	157,906,433	148,070,000	147,130,000

Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	10,673,433	10,567,396	12,126,516	17,234,388
Depreciation & Amortization	4,698,321	8,908,183	8,804,953	8,535,367
Stock Based Compensation	0	0	0	0
Change in Working Capital	-8,192,502	-12,941,130	-15,170,609	-14,205,057
Operating Cash Flow	11,264,882	14,093,294	14,467,130	15,301,360
Investing Activities
Capital Expenditure	-3,816,906	-822,846	-4,337,655	-4,633,174
Investments	-3,791,581	-789,961	-4,337,655	-4,633,174
Investing Cash Flow	-3,801,298	-850,738	-4,338,128	-5,179,323
Financing Activities
Debt Repayment	-113,940	-44,902	-36,615	-37,239
Common Stock Issued/Repurchased	-1,806,646	-2,505,832	-1,759,457	0
Dividends Paid	0	0	0	0
Financing Cash Flow	-7,471,141	-8,181,070	-7,572,272	-5,859,471
Summary
Free Cash Flow	7,447,976	13,270,448	10,129,475	10,668,186
Net Change in Cash	-7,557	5,061,486	2,556,730	4,262,566

Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Operating Activities
Net Income	10,673,433	10,567,396	12,126,516	17,234,388	13,673,811
Depreciation & Amortization	4,698,321	8,908,183	8,804,953	8,535,367	5,539,740
Stock Based Compensation	0	0	0	0	83,277
Change in Working Capital	-8,192,502	-12,941,130	-15,170,609	-14,205,057	-11,262,362
Operating Cash Flow	11,264,882	14,093,294	14,467,130	15,301,360	19,088,001
Investing Activities
Capital Expenditure	-3,816,906	-822,846	-4,337,655	-4,633,174	-4,819,304
Investments	-3,791,581	-789,961	-4,337,655	-4,633,174	-4,655,599
Investing Cash Flow	-3,801,298	-850,738	-4,338,128	-5,179,323	-4,819,597
Financing Activities
Debt Repayment	-113,940	-44,902	-36,615	-37,239	-103,335
Common Stock Issued/Repurchased	-1,806,646	-2,505,832	-1,759,457	0	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	-7,471,141	-8,181,070	-7,572,272	-5,859,471	-6,610,335
Summary
Free Cash Flow	7,447,976	13,270,448	10,129,475	10,668,186	14,268,697
Net Change in Cash	-7,557	5,061,486	2,556,730	4,262,566	7,658,069